Palantir Technologies Delivers Strong Commercial Growth Amid AI Adoption Surge

Palantir Technologies Delivers Strong Commercial Growth Amid AI Adoption Surge

Paul Chew

25 Feb 2026  |    5 views

Company Overview

Palantir Technologies Inc operates as a leading data analytics and artificial intelligence platform provider, serving both commercial enterprises and government agencies. The company’s core business centres on its Ontology platform and Artificial Intelligence Platform (AIP) tools, which enable organisations to harness data for decision-making and operational efficiency across defence, healthcare, finance, and other industries.


Financial Performance Exceeds Expectations

Palantir’s FY25 results demonstrated robust performance, with group revenue and profit after tax and minority interests (PATMI) surpassing forecasts at 106% and 121% respectively. This outperformance was driven by stronger-than-expected momentum in the US commercial segment and continued strength in government contract execution and new awards.

Looking ahead, the company projects impressive growth for 1Q26e, with group revenue expected to increase 74% year-on-year to US$1.53 billion. Adjusted operating income is forecast to rise 123% year-on-year to US$872 million, reflecting significant operating leverage benefits.


Commercial Segment Reaches New Heights

The standout performance came from Palantir’s commercial division, which achieved a new growth high with revenue increasing 82% year-on-year to US$677 million, representing a substantial acceleration from 31% growth in 4Q24. Commercial total contract value surged 161% year-on-year to US$2.6 billion in 4Q25, with half originating from the US market.

The US commercial segment particularly excelled, with revenue up 137% year-on-year to US$507 million, a dramatic improvement from 63% growth in 4Q24. This highlights increasing demand for AI production applications among large US enterprises. The segment now accounts for 36% of total group revenue, up from 22% two years prior.


Government Segment Maintains Strong Momentum

Government revenue also performed well, growing 60% year-on-year to US$730 million, up from 41% in 4Q24. This growth was supported by continued execution in existing programmes and new contract awards from the Department of Defence and civil agencies. US government revenue rose 66% year-on-year to US$570 million, whilst international government revenue increased 43% year-on-year, driven primarily by UK operations. Notably, the US Navy awarded Palantir a US$448 million contract to modernise shipbuilding supply chains.


Investment Recommendation

Phillip Securities Research maintains a BUY recommendation with a target price of US$190, revised down from US$208. Despite the lower target price, reflecting normalised long-term growth expectations and increased competitive pressure from analytical AI providers, the firm remains positive on Palantir’s prospects, citing the company’s Ontology platform advantages and AIP tools driving enterprise AI adoption beyond defence into commercial industries.


Frequently Asked Questions

Q: What drove Palantir’s strong FY25 performance?
A: FY25 group revenue and PATMI exceeded expectations at 106% and 121% of forecasts respectively, driven by stronger-than-expected US commercial momentum and continued strength in US government contract execution and new awards.

Q: How is the commercial segment performing?
A: Commercial revenue achieved a new growth high, increasing 82% year-on-year to US$677 million, with commercial total contract value growing 161% year-on-year to US$2.6 billion in 4Q25.

Q: What are Palantir’s growth projections for 1Q26e?
A: Palantir expects group revenue to grow 74% year-on-year to US$1.53 billion, with adjusted operating income projected to rise 123% year-on-year to US$872 million, driven by operating leverage.

Q: How significant is the US commercial segment?
A: US commercial revenue accelerated to 137% year-on-year growth, reaching US$507 million, and now accounts for 36% of group revenue, up from 22% two years ago.

Q: What is driving government segment growth?
A: Government revenue grew 60% year-on-year to US$730 million, supported by continued execution in existing programmes and new awards from the Department of Defence and civil agencies.

Q: What is Phillip Securities Research’s recommendation?
A: The firm maintains a BUY recommendation with a target price of US$190, down from US$208, remaining positive on Palantir’s Ontology platform advantages and AIP tools driving enterprise AI adoption.

Q: What major contract did Palantir recently secure?
A: The US Navy awarded Palantir a US$448 million contract to modernise the shipbuilding supply chain and accelerate the delivery of naval vessels.

Factsheets


This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. 


 

Disclaimer

These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Related Articles

Thomson Medical Group Ltd: Mixed Performance Amid Strategic Transformation

Company Overview Thomson Medical Group Ltd is a healthcare provider operating across Singapore, Malaysia, and...

  25 Feb 2026  |    10 views

Airbnb Inc Upgraded to Accumulate as New US Initiatives Drive Booking Growth

Company Overview Airbnb Inc operates as a global online marketplace for short-term accommodation rentals, connecting...

  25 Feb 2026  |    8 views

AppLovin Corp Maintains Strong Growth Trajectory Despite Market Challenges

Company Overview AppLovin Corp operates as a leading mobile technology platform, primarily focused on mobile...

  25 Feb 2026  |    9 views

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com